Polarean Imaging plc - First patient in Phase III FDA Clinical Trial
POLX Wed, 29 Aug 2018, 08:00am BST
We speak with Richard Hullihen, CEO of Polarean, following the successful enrolment of the first patient into the Phase III clinical trial which aims to demonstrate non-inferiority of the Company's drug/device combination
Richard Hullihen
CEO
Bastiaan Driehuys, Ph.D., Founder and Chief Scientific Officer
Thu, 13 Jun 2019, 9:00am BST
Richard Hullihen, CEO
Wed, 29 Aug 2018, 8:00am BST
Bastiaan Driehuys, Ph.D., Founder and Chief Scientific Officer
Fri, 22 Jun 2018, 9:00am BST
Richard Hullihen, CEO
Thu, 29 Mar 2018, 1:17pm BST